
Company Introduction
Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by providing innovative gene therapies with improved efficacy and safety for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment institutions and pharmaceutical enterprises. Belief BioMed has offices, research centers and manufacturing facilities in Shanghai, Hong Kong, Beijing and Suzhou China and North Carolina US.
Mission And Vision

Our Mission
Make gene therapy drugs available, affordable and healable.

Our Vision
To become the pioneer leading China’s gene therapy industry, to bring China’s gene therapy drugs to the world.
Key Milestones
Management Team

Xiao Xiao
Co-Founder, Chairman and CSO, Ph.D.
Ph.D. in Molecular Biology, University of Pittsburgh
Co-founder of Bamboo / Askbio

Jane Zheng
Co-founder and CEO, Ph.D.
PhD from Institute of Neurology, Chinese Academy of Sciences
Co-founder of Genechem / Neuron Biotech

Hao Zheng
Operations, SVP
Tianjin university Pharmaceutical engineering, Bachelor

Wei Jiang
Analytical Development, Senior Director
Shanghai Institute of Biochemistry and Cell Biology, CAS, Ph.D.

Zengmin Du
Process R&D, Senior Director
East China University of Science and Technology, Ph.D.

Yue Dun
Clinical, VP
Peking University, Master

Philip Sin
Head of Capital Markets and Corporate Development
